Evia Bio

Evia Bio™ is a life science innovation company based in Minneapolis, Minnesota, with 11 employees. The company focuses on developing and providing innovative solutions for the rapidly expanding cell therapy market. Evia Bio™ specializes in non-DMSO cryopreservation solutions, a technology developed by renowned cryobiologist Allison Hubel, PhD. These solutions are designed to preserve the integrity of cells during the cryopreservation process, ensuring their viability for use in cell therapy treatments. Evia Bio™ primarily partners with cell therapy companies, supporting them in the progression of their products through clinical trials and towards commercialization. The company's commitment to patient safety is evident in its utilization of all-natural organic compounds in its cryopreservation solutions. These compounds aim to provide a safer and more effective alternative to traditional methods, ultimately contributing to the advancement of life-saving therapies. For more information about Evia Bio™ and its innovative cryopreservation solutions, please visit www.eviabio.com.